...
首页> 外文期刊>Digestive surgery >Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.
【24h】

Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.

机译:术前CA19-9水平和淋巴结比率是切除的胰导管腺癌患者生存的独立预测指标。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The aim of this study was to identify whether preoperative CA19-9 levels might represent an independent prognostic marker for overall survival in patients undergoing resection for pancreatic ductal adenocarcinoma, and to describe the relationship between CA19-9 and tumour histology. METHODS: 109 patients who had a pancreatoduodenectomy for pancreatic ductal adenocarcinoma with recorded preoperative CA19-9 levels were identified from a prospectively maintained database (1997-2006). Multivariate analysis was conducted using a Cox proportional hazards model with continuous covariates where possible. RESULTS: The median survival of 64 patients with a preoperative CA19-9 level >150 kU/l was 10.4 months while in 45 patients with a CA19-9 level 150 kU/l were associated with a larger, more poorly differentiated tumour along with an increased likelihood of a positive resection margin status (all p < 0.05). Preoperative CA19-9 levels (p = 0.030) and lymph node ratio (p = 0.042) emerged as independent predictors of survival on multivariate analysis. CONCLUSIONS: Preoperative CA19-9 levels and lymph node ratio were significant predictors of survival in resected pancreatic ductal adenocarcinoma.
机译:背景:本研究的目的是确定术前CA19-9水平是否可以代表胰腺导管腺癌切除术患者总体生存的独立预后指标,并描述CA19-9与肿瘤组织学之间的关系。方法:从前瞻性数据库(1997-2006)中鉴定出109例行胰十二指肠切除术治疗胰腺导管腺癌并记录了术前CA19-9水平的患者。使用Cox比例风险模型在可能的情况下使用连续协变量进行多变量分析。结果:64例术前CA19-9水平> 150 kU / l的患者中位生存期为10.4个月,而45例CA19-9水平≤150kU / l的患者中位生存期为22.1个月(校正后的p = 0.012) 。在单变量分析中,淋巴结的总体状况(p = 0.011),淋巴结比率(p = 0.003)和肿瘤直径(p = 0.004)也很重要。术前CA19-9水平> 150 kU / l与更大,分化更差的肿瘤以及阳性切除切缘状态的可能性增加相关(所有p <0.05)。术前CA19-9水平(p = 0.030)和淋巴结比率(p = 0.042)在多变量分析中作为生存的独立预测指标出现。结论:术前CA19-9水平和淋巴结比率是切除的胰腺导管腺癌生存的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号